Results 111 to 120 of about 66,385 (167)
Correction to 'Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain'. [PDF]
Influenza Other Respir Viruseseuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Respiratory Syncytial Virus Infection in Adults
Antiviral Therapy, 2007Originally considered as only a paediatric pathogen, respiratory syncytial virus (RSV) has recently been shown to be a significant cause of respiratory illness among elderly and high-risk adults. Approximately 170,000 hospitalizations and 10,000 deaths associated with RSV occur annually in people over the age of 65 years in the United States.
Yoshihiko, Murata, Ann R, Falsey
openaire +4 more sources
Neonatal Respiratory Syncytial Virus Infection
New England Journal of Medicine, 1979Respiratory syncytial virus infections are thought to be uncommon in the first month of life. During a community outbreak, we prospectively studied such infection in our neonatal units. Of 82 neonates studied, 66 were hospitalized for six days or longer, and 23 (35 per cent) acquired this virus. Four infants died, two unexpectedly. Infected infants had
C B, Hall +4 more
openaire +2 more sources
Respiratory Syncytial Virus Infection: An Update
Indian Journal of Pediatrics, 2023Respiratory syncytial virus (RSV) is a highly contagious respiratory virus that can cause mild to severe illness in children. It is the leading cause of lower respiratory tract infections (LRTI) in children under the age of one year, and it can also affect older children and adults, especially those with underlying medical conditions. In the post-COVID
Akshita Soni, S. K. Kabra, Rakesh Lodha
openaire +2 more sources
Pertussis and respiratory syncytial virus infections
European Journal of Pediatrics, 2007During the winter 2005-2006, all infants
Cécile, Cosnes-Lambe +9 more
openaire +2 more sources